Literature DB >> 24532306

Positron emission tomography (PET) is not indicated in the postchemotherapy evaluation of advanced non-seminomatous testicular germ cell tumors.

J Aparicio1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24532306     DOI： 10.1007/s12094-014-1161-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  10 in total

Review 1.  EAU guidelines on testicular cancer: 2011 update.

Authors:  Peter Albers; Walter Albrecht; Ferran Algaba; Carsten Bokemeyer; Gabriella Cohn-Cedermark; Karim Fizazi; Alan Horwich; Maria Pilar Laguna
Journal:  Eur Urol       Date:  2011-05-25       Impact factor: 20.096

2.  Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

Authors:  K Fizazi; S Tjulandin; R Salvioni; J R Germà-Lluch; J Bouzy; D Ragan; C Bokemeyer; A Gerl; A Fléchon; J S de Bono; S Stenning; A Horwich; J Pont; P Albers; U De Giorgi; M Bower; A Bulanov; G Pizzocaro; J Aparicio; C R Nichols; C Théodore; J T Hartmann; H J Schmoll; S B Kaye; S Culine; J P Droz; C Mahé
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

Review 3.  Contemporary management of postchemotherapy testis cancer.

Authors:  Siamak Daneshmand; Peter Albers; Sophie Dorothea Fosså; Axel Heidenreich; Christian Kollmannsberger; Susan Krege; Craig Nichols; Jan Oldenburg; Lori Wood
Journal:  Eur Urol       Date:  2012-08-20       Impact factor: 20.096

4.  SEOM clinical guidelines for diagnosis and treatment of testicular seminoma (2010).

Authors:  Jorge Aparicio; Javier Sastre; José Ramón Germà; Dolores Isla
Journal:  Clin Transl Oncol       Date:  2011-08       Impact factor: 3.405

5.  SEOM guidelines: non-seminomatous germ cell cancer (NSGCC).

Authors:  Pablo Maroto; Xavier Garcí Del Muro; Javier Sastre; Dolores Isla
Journal:  Clin Transl Oncol       Date:  2011-08       Impact factor: 3.405

6.  2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

Authors:  M Bachner; Y Loriot; M Gross-Goupil; P A Zucali; A Horwich; J-R Germa-Lluch; C Kollmannsberger; F Stoiber; A Fléchon; K Oechsle; S Gillessen; J Oldenburg; G Cohn-Cedermark; G Daugaard; F Morelli; A Sella; S Harland; M Kerst; J Gampe; C Dittrich; K Fizazi; M De Santis
Journal:  Ann Oncol       Date:  2011-04-02       Impact factor: 32.976

7.  The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.

Authors:  Anna C Pfannenberg; Karin Oechsle; Carsten Bokemeyer; Christian Kollmannsberger; Bernhard M Dohmen; Roland Bares; Jörg T Hartmann; Reinhard Vonthein; Claus D Claussen
Journal:  World J Urol       Date:  2004-01-21       Impact factor: 4.226

8.  2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.

Authors:  Maria De Santis; Alexander Becherer; Carsten Bokemeyer; Franz Stoiber; Karin Oechsle; Franz Sellner; Alois Lang; Kurt Kletter; Bernhard M Dohmen; Christian Dittrich; Jörg Pont
Journal:  J Clin Oncol       Date:  2004-03-15       Impact factor: 44.544

Review 9.  Contemporary management of stage I and II seminoma.

Authors:  Peter Chung; Padraig Warde
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

10.  Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.

Authors:  J Beyer; P Albers; R Altena; J Aparicio; C Bokemeyer; J Busch; R Cathomas; E Cavallin-Stahl; N W Clarke; J Claßen; G Cohn-Cedermark; A A Dahl; G Daugaard; U De Giorgi; M De Santis; M De Wit; R De Wit; K P Dieckmann; M Fenner; K Fizazi; A Flechon; S D Fossa; J R Germá Lluch; J A Gietema; S Gillessen; A Giwercman; J T Hartmann; A Heidenreich; M Hentrich; F Honecker; A Horwich; R A Huddart; S Kliesch; C Kollmannsberger; S Krege; M P Laguna; L H J Looijenga; A Lorch; J P Lotz; F Mayer; A Necchi; N Nicolai; J Nuver; K Oechsle; J Oldenburg; J W Oosterhuis; T Powles; E Rajpert-De Meyts; O Rick; G Rosti; R Salvioni; M Schrader; S Schweyer; F Sedlmayer; A Sohaib; R Souchon; T Tandstad; C Winter; C Wittekind
Journal:  Ann Oncol       Date:  2012-11-14       Impact factor: 32.976
  10 in total
  1 in total

Review 1.  Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.

Authors:  Xuan Zong; Jia-Xin Yang; Ying Zhang
Journal:  J Ovarian Res       Date:  2019-12-13       Impact factor: 4.234
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.